Citigroup’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-265,600
| Closed | -$30K | – | 7950 |
|
|
2018
Q4 | $30K | Buy |
265,600
+29,100
| +12% | +$19.1K | ﹤0.01% | 6654 |
|
|
2018
Q3 | $402K | Sell |
236,500
-141,500
| -37% | -$253K | ﹤0.01% | 4536 |
|
|
2018
Q2 | $658K | Sell |
378,000
-458,000
| -55% | -$792K | ﹤0.01% | 3802 |
|
|
2018
Q1 | $1.53M | Buy |
836,000
+299,300
| +56% | +$632K | ﹤0.01% | 2848 |
|
|
2017
Q4 | $1.2M | Buy |
536,700
+291,900
| +119% | +$726K | ﹤0.01% | 3171 |
|
|
2017
Q3 | $710K | Buy |
244,800
+146,800
| +150% | +$501K | ﹤0.01% | 3731 |
|
|
2017
Q2 | $436K | Buy |
98,000
+50,400
| +106% | +$208K | ﹤0.01% | 4114 |
|
|
2017
Q1 | $222K | Sell |
47,600
-37,200
| -44% | -$216K | ﹤0.01% | 4588 |
|
|
2016
Q4 | $516K | Buy |
84,800
+68,100
| +408% | +$356K | ﹤0.01% | 4349 |
|
|
2016
Q3 | $92K | Sell |
16,700
-20,700
| -55% | -$96.9K | ﹤0.01% | 5260 |
|
|
2016
Q2 | $142K | Sell |
37,400
-5,800
| -13% | -$19.7K | ﹤0.01% | 4802 |
|
|
2016
Q1 | $119K | Buy |
43,200
+18,600
| +76% | +$67.4K | ﹤0.01% | 5541 |
|
|
2015
Q4 | $139K | Buy |
24,600
+12,500
| +103% | +$76.2K | ﹤0.01% | 5070 |
|
|
2015
Q3 | $64K | Sell |
12,100
-10,400
| -46% | -$80.5K | ﹤0.01% | 5271 |
|
|
2015
Q2 | $187K | Buy |
+22,500
| New | +$109K | ﹤0.01% | 4491 |
|
Other funds holding SGYP
Citigroup's SGYP Position: Q1 2019 in Review
Citigroup sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 716,402 shares — an estimated $82K sold.
Citigroup first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $5.21M in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Citigroup reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Citigroup sold 716,402 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $82K.
- Citigroup first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Citigroup's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.21M in Q4 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.